Movatterモバイル変換

[0]ホーム
URL:

MY190433A - Heterocyclic compounds and uses thereof - Google Patents

Heterocyclic compounds and uses thereof

Info

Publication number
MY190433A
MY190433AMYPI2017000112AMYPI2017000112AMY190433AMY 190433 AMY190433 AMY 190433AMY PI2017000112 AMYPI2017000112 AMY PI2017000112AMY PI2017000112 AMYPI2017000112 AMY PI2017000112AMY 190433 AMY190433 AMY 190433A
Authority
MY
Malaysia
Prior art keywords
egfr
pyrimidine
disclosed
pharmaceutical compositions
compositions containing
Prior art date
Application number
MYPI2017000112A
Inventor
Juswinder Singh
Kwangho Lee
Deqiang Niu
Russell C Petter
Matthew Frank Baevsky
Original Assignee
Celgene Car Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Car LlcfiledCriticalCelgene Car Llc
Publication of MY190433ApublicationCriticalpatent/MY190433A/en

Links

Landscapes

Abstract

Heterocyclic pyrimidine compounds that modulate mutant-selective epidermal growth factor receptor (EGFR) kinase activity are disclosed. Selectivity in inhibition of various mutant-EGFR is disclosed. Pharmaceutical compositions containing the pyrimidine derivatives, and methods of treating diseases associated with EGFR kinase activity comprising administration of the pyrimidine derivatives or pharmaceutical compositions containing the pyrimidine derivative, are described. [No suitable figure]
MYPI2017000112A2010-11-012011-10-31Heterocyclic compounds and uses thereofMY190433A (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US40908010P2010-11-012010-11-01
US41182910P2010-11-092010-11-09
US41233010P2010-11-102010-11-10

Publications (1)

Publication NumberPublication Date
MY190433Atrue MY190433A (en)2022-04-21

Family

ID=56761369

Family Applications (1)

Application NumberTitlePriority DateFiling Date
MYPI2017000112AMY190433A (en)2010-11-012011-10-31Heterocyclic compounds and uses thereof

Country Status (2)

CountryLink
AU (1)AU2016210613B2 (en)
MY (1)MY190433A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
AU2009262068C1 (en)*2008-06-272015-07-02Celgene Car LlcHeteroaryl compounds and uses thereof

Also Published As

Publication numberPublication date
AU2016210613B2 (en)2018-03-01
AU2016210613A1 (en)2016-08-18

Similar Documents

PublicationPublication DateTitle
PH12015501483A1 (en)Heterocyclic compounds and uses thereof
PH12015501965A1 (en)Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
PH12014501504A1 (en)THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES
AU2012284088A8 (en)Heterocyclic compounds and uses thereof
WO2012064973A3 (en)Heterocyclic compounds and uses thereof
WO2014011900A3 (en)Inhibitors of the fibroblast growth factor receptor
NZ630457A (en)Compounds useful as inhibitors of atr kinase
MX342873B (en)Substituted pyrazolo-quinazoline derivatives as kinase inhibitors.
SG10201902074UA (en)Heterocyclic compounds and uses thereof
MY158193A (en)Morpholino pyrimidines and their use in therapy
SG11201408052WA (en)IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AS KINASE INHIBITORS
MY159327A (en)Jak kinase modulating quinazoline derivatives and methods of use thereof
WO2012017239A3 (en)4-(1h-indol-3-yl) -pyrimidines as alk inhibitors
MY175979A (en)Certain chemical entities, compositions and methods
WO2010005876A3 (en)Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
WO2009007749A3 (en)Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
NZ630721A (en)Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
WO2011093672A3 (en)Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase
MX2009011950A (en)Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors.
WO2014033447A3 (en)Diaryl urea derivatives as p38 map kinase inhibitors
MY167575A (en)Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
MX2010010505A (en)5imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes.
WO2012030944A3 (en)Quinoline and isoquinoline derivatives for use as jak modulators
MX2010009743A (en)Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members.
MX2014008864A (en)Triazolo[4,5-d]pyrimidine derivatives.
[8]ページ先頭
©2009-2025 Movatter.jp